AKT1 and neoplasm: For example, we observed upregulation of PR130 and its enhanced binding to V5-tagged PP2A-Aα after trametinib treatment at the latest time point; in certain cases, PR130 is classified as tumor-promoting due to its modulation of PI3K/AKT and WNT signaling cascades (46).